Effects of rolipram on responses to acute and chronic antigen exposure in monkeys

American Journal of Respiratory and Critical Care Medicine

Volumn 149, Issue 5, 1994, Pages 1153-1159

  Turner, Claudia R ^a   Andresen, Catherine J ^a   Smith, Wilhemina B ^a   Watson, John W ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHODIESTERASE I; ROLIPRAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE FUNCTION; LYMPHOCYTIC INFILTRATION; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST;

EID: 0028231180     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.149.5.8173755     Document Type: Article

References (35)

1. Barnes PJ. Our changing understanding of asthma. Respir Med 1989; 83S:17-23.
2. Holgate ST, Twentyman OP, Rafferty P, Beasley R, Hutson PA, Robinson C, Church MK. Primary and secondary effector cells in the pathogenesis of asthma. Int Arch Allergy Appl Immunol 1987;82:498-506.
3. Bruijnzeel PLB. Contribution of eosinophil derived mediators in asthma. Int Arch Appl Immunol 1989;90:57-63.
4. Macklem PT. A hypothesis linking bronchial hyperreactivity and airway inflammation: implications for therapy. Ann Allergy 1990;64:113-6.
5. Torphy TJ, Undem BJ. Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax 1991;46:512-23.
6. Persson CGA. Overview of effects of theophylline. J Allergy Clin Immunol 1986;78:780-7.
7. Beavo JA. Multiple isozymes of cyclic nucleotide phosphodiesterase. Adv Second Messenger Phosphoprotein Res 1988;22:1-38.
8. Kuehl FA, Zanetti M, Soderman DD, Miller DK, Ham EA. Cyclic AMP-dependent regulation of lipid mediators in white cells: a unifying concept for explaining the efficacy of theophylline in asthma. Am Rev Respir Dis 1987;136:210-3.
9. Bourne HR, Lichtenstein LM, Melmon KL, Henney CS, Weinstein Y, Shearer GM. Modulation of inflammation and immunity by cyclic AMP. Science 1974;184:19-28.
10. Silver PJ, Hammel LT, Perrone MH, Bentley RG, Bushover CR, Evans DB Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac, arterial and airway smooth muscle. Eur J Pharmacol 1988;150:85-94.
11. Gundel RH, Gerritsen M, Gleich GJ, Wegner CD. Repeated antigen inhalation results in a prolonged airway eosinophilia and airway hyperresponsiveness in primates. J Appl Physiol 1990;68(2):779-86
12. Gundel RH, Wegner CD, Letts LG. Antigen-induced acute and late-phase responses in primates. Am Rev Respir Dis 1992;146:369-73.
13. Schudt C, Winder S, Muler B, Ukena D. Zardaverine as a selective inhibitor of phosphodiesterase enzymes. Biochem Pharmacol 1991;42: 153-62.
14. Krause W, Kuhne G. Pharmacokinetics of rolipram in the rhesus and cynomolgus monkeys, the rat and the rabbit: studies on species differences. Xenobiotica 1988;18:561-71.
15. Wegner CD, Jackson AC, Berry JD, Gillespie JR. Dynamic respiratory mechanics in monkeys measured by forced oscillations. Respir Physiol 1984;55:47-61.
16. Daniel WW. Biostatistics: a foundation for analysis in the health sciences, 2nd ed. New York: John W. Wiley and Sons, 1978:135-42.
17. Torphy TJ, Livi GP, Christensen SB. Novel phosphodiesterase inhibitors for the therapy of asthma. DN & P 1993;6(4):203-14.
18. Peachell PT, Undem BJ, Schleimer RP, MacGlashen DW, Lichtenstein LM, Cieslinski LB, Torphy TJ. Preliminary identification and role of phosphodiesterase isozymes in human basophils. J Immunol 1991;148: 2503-10.
19. m cyclic AMP phosphodiesterase inhibition in tracheal relaxation and bronchodilation in the guinea pig. J Pharmacol Exp Ther 1989;251;199-206.
20. Ward AJM, McKenniff M, Evans JM, Page CP, Costello JF. Theophylline-an immunomodulatory role in asthma? Am Rev Respir Dis 1993; 147:518-23.
21. Broide DH, Lotz M, Cuomo AJ, Coburn DA, Federman EC, Wasserman SI. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol 1992;89:958-67.
22. Zhang Y, Ramos BF, Jakschik BA. Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science 1992;258:1957-9.
23. Slungaard A, Vercellotte GM, Walker G, Neloon RD, Jacob HE. Tumor necrosis factor α/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium. J Exp Med 1990;171:2025-41.
24. Mullin JM, Snock KV. Effect of tumor necrosis factor on epithelial tight junctions and transepithelial permeability. Cancer Res 1990;50:2172-6.
25. Kips JC, Tavernier J, Rauwels RA. Tumor necrosis factor causes bronchial hyperresponsiveness in rats. Am Rev Respir Dis 1992;145:332-6.
26. Peveri P, Walz A, Dewald B, Baggiolini M. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med 1988; 167:1547-52.
27. Bazzoni F, Cassatella MA, Rossi F, Ceska M, Dewald B, Baggiolini M. Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide1/interleukin 8. J Exp Med 1991;173:771-8.
28. Dent G, Giembycz MA, Rabe KF, Barnes PJ. Inhibition of guinea pig eosinophil cyclic nucleotide PDE activity and opsonized zymozan-stimulated respiratory burst by type IV-selective PDE inhibitors. Br J Pharmacol 1991;103:1339-46.
29. Nielson CP, Vestal RE, Sturm RJ, Heaslip R. Effect of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst. J Allergy Clin Immunol 1990;86:801-8.
30. Giembycz MA, Dent G. Prospects for selective cyclic nucleotide phosphodiesterase inhibitors in the treatment of bronchial asthma. Clin Exp Allergy 1992;22:337-44.
31. Wanner A, Abraham WM, Douglas JS, Drazen JM, Richerson HB, Ram JS. Models of airway hyperresponsiveness. Am Rev Respir Dis 1990; 141:253-7.
32. Woolcock AJ, Salome CM, Keena VA. Therapy for bronchial hyperreactivity: reducing the severity of bronchial hyperresponsiveness. Am Rev Respir Dis 1991;143:S75-7.
33. Hui KP, Barnes NC. Lung function improvement in asthma with a cysteinyl leukotriene receptor antagonist. Lancet 1991;337:1062-3.
34. Gundel RH, Kinkade P, Torcellini CA, Clarke CC, Watrous J, Desai S, Homon CA, Farina PR, Wegner CD. Antigen-induced mediator release in primates. Am Rev Respir Dis 1991;144:76-82.
35. Gundel RH, Torcellini CA, Clarke CC, Desai S, Lazar ES, Wegner CD. The effects of 5-lipoxygenase inhibitor on antigen-induced mediator release, late-phase bronchoconstriction and cellular infiltrates in primates. Adv Prostaglandin Thromboxane Leukotriene Res 1990;21:457-60.